5-hydroxythiabendazole has been researched along with mocetinostat in 1 studies
Studies (5-hydroxythiabendazole) | Trials (5-hydroxythiabendazole) | Recent Studies (post-2010) (5-hydroxythiabendazole) | Studies (mocetinostat) | Trials (mocetinostat) | Recent Studies (post-2010) (mocetinostat) |
---|---|---|---|---|---|
17 | 0 | 3 | 21,735 | 390 | 8,606 |
Protein | Taxonomy | 5-hydroxythiabendazole (IC50) | mocetinostat (IC50) |
---|---|---|---|
Histone deacetylase 3 | Homo sapiens (human) | 0.7851 | |
Nuclear receptor corepressor 1 | Homo sapiens (human) | 0.022 | |
Cytochrome P450 3A4 | Homo sapiens (human) | 0.57 | |
Cytochrome P450 2D6 | Homo sapiens (human) | 0.102 | |
Cytochrome P450 2C19 | Homo sapiens (human) | 0.102 | |
Histone deacetylase 4 | Homo sapiens (human) | 0.5717 | |
Histone deacetylase 1 | Homo sapiens (human) | 0.3433 | |
Histone deacetylase 7 | Homo sapiens (human) | 0.6725 | |
Histone deacetylase 2 | Homo sapiens (human) | 0.3537 | |
Histone deacetylase 11 | Homo sapiens (human) | 0.6386 | |
Histone deacetylase 8 | Homo sapiens (human) | 0.6725 | |
Histone deacetylase 6 | Homo sapiens (human) | 0.5717 | |
Histone deacetylase 5 | Homo sapiens (human) | 0.6725 | |
Nuclear receptor corepressor 2 | Homo sapiens (human) | 0.045 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dalvie, DK; Jamieson, JD; Smith, EB; Stevens, GJ; Yanochko, GM | 1 |
1 other study(ies) available for 5-hydroxythiabendazole and mocetinostat
Article | Year |
---|---|
Myeloperoxidase-mediated bioactivation of 5-hydroxythiabendazole: a possible mechanism of thiabendazole toxicity.
Topics: Animals; Antifungal Agents; Biotransformation; Caspase 3; Caspase 7; Cell Line; Epithelial Cells; L-Lactate Dehydrogenase; Male; Necrosis; Neutrophils; Peroxidase; Rats; Rats, Wistar; Rutin; Thiabendazole | 2011 |